News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,438 Results
Type
Article (34513)
Company Profile (81)
Press Release (343842)
Multimedia
Podcasts (70)
Webinars (6)
Section
Business (106606)
Career Advice (619)
Deals (14543)
Drug Delivery (78)
Drug Development (50502)
Employer Resources (54)
FDA (7937)
Job Trends (8282)
News (168914)
Policy (16711)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2331)
Academic (1)
Accelerated approval (39)
ADA (16)
Adcomms (24)
Allergies (63)
Alliances (28521)
ALS (116)
Alzheimer's disease (963)
Antibody-drug conjugate (ADC) (556)
Approvals (8327)
Artificial intelligence (452)
ASCO (335)
Autoimmune disease (193)
Automation (19)
Bankruptcy (121)
Best Places to Work (7165)
BIO (44)
BIOSECURE Act (17)
Biosimilars (154)
Biotechnology (71)
Bladder cancer (217)
Brain cancer (84)
Breast cancer (867)
Cancer (6739)
Cardiovascular disease (209)
Career advice (556)
Career pathing (14)
CAR-T (318)
CDC (40)
Celiac Disease (2)
Cell therapy (716)
Cervical cancer (60)
Clinical research (43369)
Collaboration (1404)
Commercialization (1)
Company closure (6)
Compensation (485)
Complete response letters (45)
COVID-19 (1768)
CRISPR (67)
C-suite (657)
Cystic fibrosis (66)
Data (5530)
Decentralized trials (3)
Denatured (12)
Depression (75)
Dermatology (50)
Diabetes (257)
Diagnostics (4767)
Digital health (35)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (193)
Drug pricing (154)
Drug shortages (12)
Duchenne muscular dystrophy (99)
Earnings (31852)
Editorial (33)
Employer branding (6)
Employer resources (53)
Events (59188)
Executive appointments (581)
FDA (10279)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (21)
Funding (1210)
Gene editing (123)
Generative AI (26)
Gene therapy (335)
GLP-1 (398)
Government (3527)
Grass and pollen (2)
Guidances (209)
Healthcare (12220)
Hematology (168)
HIV (57)
Huntington's disease (12)
IgA nephropathy (38)
Immunology and inflammation (144)
Immuno-oncology (116)
Indications (149)
Infectious disease (1964)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (69)
Intellectual property (154)
Interviews (93)
IPO (7380)
IRA (35)
Job creations (1387)
Job search strategy (489)
JPM (39)
Kidney cancer (24)
Labor market (44)
Layoffs (261)
Leadership (9)
Legal (3030)
Liver cancer (110)
Longevity (17)
Lung cancer (903)
Lymphoma (456)
Machine learning (42)
Management (18)
Manufacturing (555)
Marketing (5)
MASH (101)
Medical affairs (1)
Medical device (4982)
Medtech (5039)
Mergers & acquisitions (7830)
Metabolic disorders (626)
mRNA (168)
Multiple sclerosis (98)
NASH (5)
Neurodegenerative disease (199)
Neuropsychiatric disorders (34)
Neuroscience (1688)
NextGen: Class of 2026 (4050)
Non-profit (4061)
Now hiring (21)
Obesity (249)
Opinion (167)
Ovarian cancer (253)
Pain (134)
Pancreatic cancer (375)
Parkinson's disease (163)
Partnered (21)
Patents (335)
Patient recruitment (474)
Peanut (15)
People (32431)
Pharmaceutical (15)
Pharmacy benefit managers (19)
Phase 1 (15195)
Phase 2 (18886)
Phase 3 (13546)
Pipeline (5861)
Policy (233)
Postmarket research (1479)
Preclinical (6616)
Press Release (30)
Prostate cancer (362)
Psychedelics (36)
Radiopharmaceuticals (346)
Rare diseases (546)
Real estate (2641)
Recruiting (25)
Regulatory (13717)
Reports (19)
Research institute (2280)
Resumes & cover letters (74)
Rett syndrome (4)
RNA editing (10)
RSV (38)
Schizophrenia (83)
Series A (164)
Series B (120)
Sickle cell disease (70)
Special edition (11)
Spinal muscular atrophy (70)
Sponsored (19)
Startups (2030)
State (2)
Stomach cancer (21)
Supply chain (70)
Tariffs (68)
The Weekly (58)
Vaccines (717)
Venture capital (70)
Weight loss (152)
Women's health (89)
Worklife (5)
Date
Today (12)
Last 7 days (233)
Last 30 days (1011)
Last 365 days (16499)
2026 (9235)
2025 (16428)
2024 (19383)
2023 (22014)
2022 (29055)
2021 (31199)
2020 (30085)
2019 (27137)
2018 (20164)
2017 (16831)
2016 (16637)
2015 (19292)
2014 (14628)
2013 (12015)
2012 (12545)
2011 (13089)
2010 (11709)
Location
Africa (428)
Alabama (74)
Alaska (4)
Arizona (181)
Arkansas (9)
Asia (25127)
Australia (4617)
California (7337)
Canada (2125)
China (1238)
Colorado (322)
Connecticut (341)
Delaware (312)
Europe (50001)
Florida (1121)
Georgia (206)
Hawaii (1)
Idaho (32)
Illinois (688)
India (53)
Indiana (377)
Iowa (16)
Japan (356)
Kansas (51)
Kentucky (35)
Louisiana (33)
Maine (15)
Maryland (997)
Massachusetts (4874)
Michigan (113)
Minnesota (319)
Mississippi (4)
Missouri (109)
Montana (20)
Nebraska (13)
Nevada (75)
New Hampshire (56)
New Jersey (2290)
New Mexico (21)
New York (2382)
North Carolina (672)
North Dakota (4)
Northern California (3820)
Ohio (198)
Oklahoma (10)
Oregon (14)
Pennsylvania (1345)
Puerto Rico (17)
Rhode Island (20)
South America (518)
South Carolina (32)
South Dakota (2)
Southern California (2902)
Tennessee (110)
Texas (1572)
United States (26661)
Utah (180)
Vermont (2)
Virginia (172)
Washington D.C. (57)
Washington State (770)
West Virginia (3)
Wisconsin (96)
Wyoming (1)
378,438 Results for "national cancer institute nci".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImpriMed CEO Dr. Sungwon Lim Invited to National Cancer Institute Panel on Commercializing Functional Precision Medicine
July 1, 2026
·
3 min read
Press Releases
Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx
March 10, 2026
·
6 min read
Press Releases
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
May 29, 2026
·
3 min read
Press Releases
Tryfacta, Inc. Awarded National Institutes of Health (NIH) Healthcare Staffing Contract
June 17, 2026
·
2 min read
Press Releases
National Cancer Institute Awards Rosalind Franklin University Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
March 26, 2026
·
1 min read
Press Releases
Karmanos Cancer Institute Reaches Historic Growth Milestone, Positioning Itself as a Leader in Oncology Care Delivery
June 22, 2026
·
7 min read
Press Releases
Florida Cancer Specialists & Research Institute Advances the Future of Cancer Care
May 28, 2026
·
9 min read
Press Releases
Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology
March 24, 2026
·
2 min read
Press Releases
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
June 18, 2026
·
6 min read
Press Releases
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
April 15, 2026
·
9 min read
1 of 37,844
Next
